newsfilter
← Latest News
GlobeNewswire·

Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference

REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (NASDAQ:BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that